Jackie Hunter

Source: Wikipedia, the free encyclopedia.
For the Canadian actor, singer and musician, see Jackie Hunter (entertainer).

Jackie Hunter
Born
Ann Jacqueline Hunter
Bedford College, London
Known for
AI and Drug discovery
Awards
FRSB (2016)
Scientific career
Institutions
ThesisChemical communication, aggression and sexual behaviour in the owl monkey (Aotus trivirgatus griseimembra) (1981)
Websitebenevolent.ai/blog/

Ann Jacqueline Hunter

Imperial College. She is Chair of the Trustees of the Sainsbury Laboratories at Norwich, chair of the board of the Stevenage Bioscience Catalyst and chair of the board of Brainomix. She was previously CEO of the Biotechnology and Biological Sciences Research Council.[5][7]

Education

Jackie Hunter was educated at Selwyn School, Matson, Gloucestershire and at the

King's School, Gloucester.[8] She achieved a BSc in Physiology and Psychology at Bedford College, University of London in 1977 and whilst there represented the college on the TV programme University Challenge in 1976. She was awarded her PhD[9] for work carried out at London Zoo entitled 'Olfaction, aggression and sexual behaviour of owl monkeys (genus Aotus)[9]
in 1981.

Career

Hunter undertook a

GSK, she became head of the Neurology and GI Centre of Excellence for Drug Discovery and Site Head at the GSK site in Harlow
, Essex.

In 2008, Hunter developed GSK's external innovation strategy and was responsible for developing the concept of the Stevenage Bioscience Catalyst and obtaining funding from government and other bodies.[citation needed] In 2010, she left GSK to establish OI Pharma Partners.[4][5][10][11][12][13][14][15] which was established as a consultancy for the promotion of open innovation in the life sciences, working with governments, academic organisations and companies to formulate open innovation strategies and best practice.

In 2013, Hunter was appointed CEO of the BBSRC.

BBSRC and joined Stratified Medical which became BenevolentAI, establishing the drug discovery arm of the organisation. She retired from BenevolentAI in 2020 but remains as a board director. In 2019 she was appointed chair of the trustees of the Sainsbury Laboratories at Norwich. In 2020 she was also appointed as chair of the board of the Stevenage Bioscience Catalyst and chair of the board of Brainomix
, an AI enabled imaging company.

Awards

References

  1. ^ a b "New Fellows | The Academy of Medical Sciences". Acmedsci.ac.uk. Retrieved 7 June 2017.
  2. ^ a b c "Royal Holloway, University of London Dr Jackie Hunter CBE (1956–)". Archived from the original on 24 September 2016. Retrieved 11 November 2013.
  3. ^ Jackie Hunter's publications indexed by the Scopus bibliographic database. (subscription required)
  4. ^ a b "OI Pharma Partners – Open Innovation in Healthcare". Archived from the original on 31 October 2013.
  5. ^ a b c "Chief Executive's biography: Professor Jackie Hunter". Archived from the original on 4 December 2013.
  6. ^ "Benevolent AI's Dr Jackie Hunter discusses defining innovation - Babraham Research Campus". www.babraham.com. Retrieved 8 January 2020.
  7. ^ a b Jackie Hunter to be next BBSRC chief, Times Higher Education, 4 June 2013
  8. ^ "Jackie Hunter PhD CBE FBPharmacolS LinkedIn profile". Archived from the original on 8 November 2013.
  9. ^ a b Hunter, A. Jackie (1981). Chemical communication, aggression and sexual behaviour in the owl monkey (Aotus trivirgatus griseimembra) (PhD thesis). Bedford College, London.
  10. PMID 21464073
    .
  11. PMID 10485925
    .
  12. S2CID 29864514
    .
  13. S2CID 7052019
    .
  14. S2CID 9028853
    .
  15. S2CID 7052019
    .
  16. ^ "Bioscience innovation leader appointed as next BBSRC Chief Executive". Archived from the original on 4 December 2013.
  17. ^ "Press release: New chief executive for the Biotechnology and Biological Sciences Research Council". Archived from the original on 14 May 2014.

External links

Government offices
Preceded by Incumbent
Retrieved from "https://en.wikipedia.org/w/index.php?title=Jackie_Hunter&oldid=1198396801"